Harish Shantharam
Nessuna posizione attualmente
Storia della carriera di Harish Shantharam
Precedenti posizioni note di Harish Shantharam
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 24/01/2024 | 22/03/2024 |
| Direttore Finanziario/CFO | 22/05/2023 | 22/03/2024 | |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2011 | 01/05/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2004 | 01/11/2011 |
Formazione di Harish Shantharam
| UCLA Anderson School of Management | Masters Business Admin |
| The University of Texas at Arlington | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
- Borsa valori
- Insiders
- Harish Shantharam
- Esperienza
